Glycosaminoglycans have anti-inflammatory properties and interact with a variety of soluble and membrane-bound molecules. Little is known about their effects on B cells and humoral immune responses. We show that CS but not dextran or other glycosaminoglycans induces a pronounced proliferation of B cells in vitro compared with TLR4 or TLR9 ligands. With the use of inhibitors and KO mice, we demonstrate that this proliferation is mediated by the tyrosine kinases BTK and Syk but independent of CD44. Antibodies against Ig-α or Ig-β completely block CS-induced B cell proliferation. Injection of CS in mice for 4-5 days expands B cells in the spleen and results in a marked increase of CD138(+) cells in the spleen that is dependent on BTK but independent of CD4(+) T cells. Long-term treatment with CS for 14 days also increases CD138(+) cells in the bone marrow. When mice were immunized with APC or collagen and treated with CS for up to 14 days during primary or after secondary immune responses, antigen-specific humoral immune responses and antigen-specific CD138(+) plasma cells in the bone marrow were reduced significantly. These data show that CD138(+) cells, induced by treatment with CS, migrate into the bone marrow and may displace other antigen-specific plasma cells. Overall, CS is able to interfere markedly with primary and fully established humoral immune responses in mice.

2 University Hospital Regensburg Regensburg Germany

Departments of Internal Medicine 1 and

Institute for Animal Physiology University of Munich Munich Germany

Institute of Molecular Genetics Czech Academy of Sciences Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc14074279

003      

CZ-PrNML

005      

20141009093008.0

007      

ta

008      

141006s2014 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1189/jlb.1A0913-502R $2 doi

035    __

$a (PubMed)24555985

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Brühl, Hilke $u Departments of Internal Medicine I and.

245    10

$a Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses / $c H. Brühl, J. Cihak, N. Goebel, Y. Talke, K. Renner, F. Hermann, M. Rodriguez-Gomez, B. Reich, J. Plachý, M. Stangassinger, M. Mack,

520    9_

$a Glycosaminoglycans have anti-inflammatory properties and interact with a variety of soluble and membrane-bound molecules. Little is known about their effects on B cells and humoral immune responses. We show that CS but not dextran or other glycosaminoglycans induces a pronounced proliferation of B cells in vitro compared with TLR4 or TLR9 ligands. With the use of inhibitors and KO mice, we demonstrate that this proliferation is mediated by the tyrosine kinases BTK and Syk but independent of CD44. Antibodies against Ig-α or Ig-β completely block CS-induced B cell proliferation. Injection of CS in mice for 4-5 days expands B cells in the spleen and results in a marked increase of CD138(+) cells in the spleen that is dependent on BTK but independent of CD4(+) T cells. Long-term treatment with CS for 14 days also increases CD138(+) cells in the bone marrow. When mice were immunized with APC or collagen and treated with CS for up to 14 days during primary or after secondary immune responses, antigen-specific humoral immune responses and antigen-specific CD138(+) plasma cells in the bone marrow were reduced significantly. These data show that CD138(+) cells, induced by treatment with CS, migrate into the bone marrow and may displace other antigen-specific plasma cells. Overall, CS is able to interfere markedly with primary and fully established humoral immune responses in mice.

650    _2

$a zvířata $7 D000818

650    _2

$a antigeny CD44 $x genetika $x imunologie $7 D018960

650    _2

$a buňky kostní dřeně $x imunologie $7 D001854

650    _2

$a pohyb buněk $x účinky léků $x imunologie $7 D002465

650    _2

$a proliferace buněk $x účinky léků $7 D049109

650    _2

$a chondroitin sulfáty $x farmakologie $7 D002809

650    _2

$a humorální imunita $x účinky léků $x genetika $7 D056724

650    _2

$a intracelulární signální peptidy a proteiny $x genetika $x imunologie $7 D047908

650    _2

$a aktivace lymfocytů $x účinky léků $x genetika $7 D008213

650    _2

$a myši $7 D051379

650    _2

$a myši inbrední BALB C $7 D008807

650    _2

$a myši knockoutované $7 D018345

650    _2

$a plazmatické buňky $x imunologie $7 D010950

650    _2

$a tyrosinkinasy $x genetika $x imunologie $7 D011505

650    _2

$a syndekan-1 $x genetika $x imunologie $7 D053668

650    _2

$a toll-like receptor 4 $x genetika $x imunologie $7 D051197

650    _2

$a toll-like receptor 9 $x genetika $x imunologie $7 D051217

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Cihak, Josef $u Institute for Animal Physiology, University of Munich, Munich, Germany; and.

700    1_

$a Goebel, Nicole $u II, University Hospital Regensburg, Regensburg, Germany;

700    1_

$a Talke, Yvonne $u II, University Hospital Regensburg, Regensburg, Germany;

700    1_

$a Renner, Kerstin $u II, University Hospital Regensburg, Regensburg, Germany;

700    1_

$a Hermann, Fabian $u II, University Hospital Regensburg, Regensburg, Germany;

700    1_

$a Rodriguez-Gomez, Manuel $u II, University Hospital Regensburg, Regensburg, Germany;

700    1_

$a Reich, Barbara $u II, University Hospital Regensburg, Regensburg, Germany;

700    1_

$a Plachý, Jîŕi $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Stangassinger, Manfred $u Institute for Animal Physiology, University of Munich, Munich, Germany; and.

700    1_

$a Mack, Matthias $u II, University Hospital Regensburg, Regensburg, Germany; matthias.mack@klinik.uni-regensburg.de.

773    0_

$w MED00002765 $t Journal of leukocyte biology $x 1938-3673 $g Roč. 96, č. 1 (2014), s. 65-72

856    41

$u https://pubmed.ncbi.nlm.nih.gov/24555985 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20141006 $b ABA008

991    __

$a 20141009093357 $b ABA008

999    __

$a ok $b bmc $g 1042162 $s 873191

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2014 $b 96 $c 1 $d 65-72 $i 1938-3673 $m Journal of leukocyte biology $n J Leukoc Biol $x MED00002765

LZP    __

$a Pubmed-20141006